日本の薬剤師におけるNINLAROリスクマネジメントプラン（RMP）資材の利用状況に関する調査

基本情報

NCT ID

NCT05882279

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

330

治験依頼者名

Takeda

概要

This is a survey among pharmacists who have instructed NINLARO therapy in ixazomib, lenalidomide and dexamethasone (IRD) dosing to patients with relapsed/refractory multiple myeloma (rrMM). The main aims of the study are: * To assess the frequency of pharmacists who have provided patients with the contents of the RMP material for patients. * To assess the frequency of pharmacists who have obtained the RMP material for patients. * To evaluate the depth of understanding of proper usage of NINLARO among pharmacists.

対象疾患

介入

依頼者（Sponsor）